Finance

Lists
Why is BDSX up 8.53%?
Dive Deeper
BDSX:NASDAQ
Biodesix Inc
$10.62
+8.53%
(+0.84) 1D
Nov 13, 11:39:41 AM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BDSX...
Open
$10.06
High
$11.32
Low
$9.93
Mkt. cap
117.82M
Avg. vol.
205.23K
Volume
169.78K
52-wk high
$31.97
52-wk low
$5.26
EPS
-$2.76
Beta
0.65
Shares outstanding
11.09M
No. of employees
334
Open
$10.06
High
$11.32
Low
$9.93
Mkt. cap
117.82M
Avg. vol.
205.23K
Volume
169.78K
52-wk high
$31.97
52-wk low
$5.26
EPS
-$2.76
Beta
0.65
Shares outstanding
11.09M
No. of employees
334
News stories
From web sources and news partners
About Biodesix Inc
CEO-
Employees334
Founded2005
HeadquartersLouisville, Colorado, United States
SectorHealth Care
IndustryHealth care provider
Websitebiodesix.com
Analyst ratings
Based on 5 analysts giving stock ratings to BDSX in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for BDSX in the last 3 months.
Highest
Current $10.62
$35.00 (+229.41%)
Average
$32.60 (+206.82%)
Lowest
$30.00 (+182.35%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
$34.00
+220%
11/09/2026
Kyle Mikson CFA
Canaccord Genuity
Buy
Reiterated
$35.00
+229.4%
11/06/2026
Max Masucci
Roth MKM
Buy
Maintained
$30.00
+182.4%
11/06/2026
Thomas Flaten
Lake Street
Buy
Maintained
$30.00
+182.4%
11/06/2026
Daniel Brennan
TD Cowen
Buy
Maintained
$34.00
+220%
11/06/2026
William Bonello
Craig-Hallum
Buy
Maintained
$40.00
+276.5%
08/06/2026
Matt Larew
William Blair
Buy
Reiterated
-
-
08/06/2026
Unknown Analyst
Roth MKM
Buy
Initiated
$32.00
+201.2%
06/24/2026
Andrew Brackmann
William Blair
Buy
Maintained
-
-
05/05/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
28.76M
25.56M
26.86M
24.04M
Cost of goods sold
4.88M
4.60M
4.82M
4.66M
Cost of revenue
4.88M
4.60M
4.82M
4.66M
Research and development expenses
2.87M
3.28M
3.14M
2.99M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22.97M
24.26M
24.28M
22.50M
Operating expense
25.84M
27.55M
27.42M
25.49M
Total operating expenses
30.72M
32.15M
32.24M
30.15M
Operating income
-1.97M
-6.60M
-5.38M
-6.11M
Other non operating income
46.00K
385.00K
-
82.00K
EBT including unusual items
-3.98M
-7.79M
-7.27M
-8.03M
EBT excluding unusual items
-3.98M
-8.19M
-7.26M
-8.03M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.98M
-7.79M
-7.27M
-8.03M
Net profit margin
-13.84%
-30.50%
-27.08%
-33.41%
Earnings per share
-
-
-
-
Interest and investment income
-
-
97.00K
-
Interest expense
-2.06M
-1.98M
-1.98M
-2.00M
Net interest expenses
-2.06M
-1.98M
-1.88M
-2.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-579.00K
-5.20M
-3.99M
-4.71M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps